Detection of human papillomavirus-16 in ovarian malignancy

British Journal of Cancer

Volumn 89, Issue 4, 2003, Pages 672-675

  Wu, Q J ^a   Guo, M ^b   Lu, Z M ^b   Li, T ^b   Qiao, H Z ^a   Ke, Y ^b  

^a INNER MONGOLIA MEDICAL COLLEGE   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Human papillomavirus 16; Ovarian malignancy; P53 tumour suppressor gene

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOGENESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VERRUCA VULGARIS; WART VIRUS;

ADULT; AGED; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, MUCINOUS; CYSTADENOCARCINOMA, SEROUS; DNA PROBES, HPV; DNA, VIRAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; OVARIAN NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARAFFIN EMBEDDING; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

EID: 0042735002     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601172     Document Type: Article

References (40)

1. Anttila M, Syrjanen S, Ji H, Saarikoski S, Syrjanen K (1999) Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol 72: 337-341
2. Anwar K, Nakakuki K, Imai H, Shiraishi T, Inuzuka M (1996) Infection of human papillomavirus (HPV) and p53 over-expression in human female genital tract carcinoma. J Pak Med Assoc 46: 220-224
3. Beckmann AM, Sherman KJ, Saran L, Weiss NS (1991) Genital-type human papillomavirus infection is not associated with surface epithelial ovarian carcinoma. Gynecol Oncol 43: 247-251
4. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265
5. Boyle P, Maisonneuve P, Autier P (2000) Update on cancer control in women. Int J Gynecol Obstet 70: 263-303
6. Chen TR, Chan PJ, Seraj IM, King A (1999) Absence of human papillomavirus E6-E7 transforming genes from HPV 16 and 18 in malignant ovarian carcinoma. Gynecol Oncol 72: 180-182
7. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH (1992) Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet 339: 1070-1073
8. Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M (1997) Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 89: 1293-1299
9. Duggan MA, Rowlands C, Kneafsey PD, Nation JG, Stuart GC (1995) Uterine atypical polypoid adenomyoma and ovarian endometrioid carcinoma: metastatic disease or dual primaries? Int J Gynecol Pathol 14: 81-86
10. Gupta J, Pilotti S, Rilke F, Shah K (1987) Association of human papillomaviruse type 16 with neoplastic lesions of the vulva and other genital sites by in situ hybridization. Am J Pathol 127: 206-215
11. Hachisuga T, Matsuo N, Iwasaka T, Sugimori H, Tsuneyoshi M (1996) Human papilloma virus and p53 overexpression in carcinomas of uterine cervix, lower uterine segment and endometrium. Pathology 28: 28-31
12. Hasegawa M, Ohoka I, Yamazaki K, Hanami K, Sugano I, Nagao T, Asoh A, Wada N, Nagao K, Ishida Y (2002) Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection. Pathol Int 52: 442-450
13. Heinzel PA, Chan SY, Ho L, O'Connor M, Balaram P, Campo MS, Fujinaga K, Kiviat N, Kuypers J, Pfister H (1995) Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol 33: 1746-1754
14. Higgins GD, Uzelin DM, Phillips GE, Burrell CJ (1991) Presence and distribution of human papillomavirus sense and antisense RNA transcripts in genital cancer. J Gen Virol 72: 885-895
15. Hildesheim A, Wang SS (2002) Host and viral genetics and risk of cervical cancer. Virus Res 89 (2): 229-240
16. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Khan T, Kiviat N, Lancaster W, Mavromara-Nazos P, Labropoulou V, Mitrani-Rosenbaum S, Norrild B, Pilai MR, Stoerker J, Syrjaene K, Syrjaene S, Tay SK, Villa LL, Wheeler CM, Williamson AL, Bernard HU (1993) The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67: 6413-6423
17. Ip SM, Wong LC, Xu CM, Cheung AN, Tsang PC, Ngan HY (2002) Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract. Gynecol Oncol 87: 104-111
18. Kaufman RH, Bornstein J, Gordon AN, Adam E, Kaplan AL, Adler-Storthz K (1987) Detection of human papillomavirus DNA in advanced epithelial ovarian carcinoma. Gynecol Oncol 27: 340-349
19. Kedzia WM, Gozdzicka-Jozefiak A, Kedzia H (1996) Human papillomavirus type 16 in ovarian serous surface papilloma. Eur J Gynaecol Oncol 17: 354-356
20. Kmet LM, Cook LS, Magliocco AM (2003) A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer 97: 389-404
21. Lai CH, Hsueh S, Lin CY, Huang MY, You GB, Chang HC, Pao CC (1992) Human papillomavirus in benign and malignant ovarian and endometrial tissues. Int J Gynecol Pathol 11: 210-215
22. Lai CH, Wang CY, Lin CY, Pao CC (1994) Detection of human papillomavirus RNA in ovarian and endometrial carcinomas by reverse transcription/polymerase chain reaction. Gynecol Obstet Invest 38: 276-280
23. Leake JF, Woodruff JD, Searle C, Daniel R, Shah KV, Currie JL (1989) Human papillomavirus and epithelial ovarian neoplasia. Gynecol Oncol 34: 268-273
24. Li T, Lu ZM, Chen KN, Guo M, Xing HP, Mei Q, Yang HH, Lechner JF, Ke Y (2001) Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis 22: 929-934
25. Mai KT, Yazdi HM, Bertrand MA, LeSaux N, Cathcart L (1996) Bilateral primary ovarian squamous cell carcinoma associated with human papilloma virus infection and vulvar and cervical intraepithelial neoplasia: a case report with review of the literature. Am J Surg Pathol 20: 767-772
26. Manolitsas TP, Lanham SA, Hitchcock A, Watson RH (1998) Synchronous ovarian and cervical squamous intraepithelial neoplasia: an analysis of HPV status. Gynecol Oncol 70: 428-431
27. Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara P, Pfister H, Tay SK, Meulen JT, Villa LL, Bernard HU (1993) Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67: 6424-6431
28. Parazzini F, Franceschi S, La Vecchia C, Chatenoud L, Di Cintio E (1997) The epidemiology of the female genital tract cancers. Int J Gynecol Cancer 7: 169-181
29. Runnebaum IB, Maier S, Tong XW, Rosenthal HE, Mobus VJ, Kieback DG, Kreienberg R (1995) Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients. Cancer Epidemiol Biomarkers Prev 4: 573-575
30. Shah KV, Howley PM (1996) Papillomaviruses. In: Fields BN, Knipe DM, Howley PM, (eds) Fields Virology, Vol. 2, pp 2077-2109. Philadelphia: Lippincott-Raven
31. Stewart ACM, Eriksson AM, Manos MM, Munoz N, Bosch FX, Peto J, Wheeler CM (1996) Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol 70: 3127-3135
32. Sworn MJ, Jones H, Letchworth AT, Herrington CS, McGee JO (1995) Squamous intraepithelial neoplasia in an ovarian cyst, cervical intraepithelial neoplasia, and human papillomavirus. Hum Pathol 26: 344-347
33. Trottier A-M, Provencher D, Mes-Masson A-M, Vauclair R, Coutlee F (1995) Absence of human papillomavirus sequences in ovarian pathologies. J Clin Microbiol 33: 1011-1013
34. Vormwald-Dogan V, Fischer B, Bludau H, Freese UK, Gissmann L, Glitz D (1992) Sense and antisense transcripts of human papillomavirus type 16 in cervical cancer. J Gen Virol 73: 1833-1838
35. Werness BA, Levine AJ, Howley PM (1990) The E6 proteins encoded by HPV-16 and 18 can complex p53 in vitro. Science 248: 76-79
36. Yamada T, Wheeler CM, Halpern AL, Stewart ACM, Hildesheim A, Jenison SA (1995) Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69: 7743-7753
37. Yamada T, Manos M, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM (1997) Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71: 2463-2472
38. Zimna K, Poreba E, Kedzia W, Gozdzicka-Jozefiak A, Kedzia H (1997) Human papillomavirus (HPV) in upper genital tract carcinomas of women. Eur J Gynaecol Oncol 18: 415-417
39. zur Hausen H (1999) Papillomaviruses in human cancers. Proc Assoc Am Phys 111: 1-7
40. zur Hausen H (2002) Papillomavirus and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350